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Technical Report
Abstract
Purpose: This work investigated the accuracy of prowess treatment planning system (TPS) in dose calculation in a homogenous
phantom for symmetric and asymmetric field sizes using collapse cone convolution/superposition algorithm (CCCS). Methods:
The measurements were carried out at source-to-surface distance (SSD) set to 100 cm for 6 and 10 MV photon beams. Data for a
full set of measurements for symmetric fields and asymmetric fields, including inplane and crossplane profiles at various depths
and percentage depth doses (PDDs) were obtained. Results: The results showed that the asymmetric collimation dose lead to
significant errors (up to approximately 7%) in dose calculations if changes in primary beam intensity and beam quality. The
largest difference in the isodose curves was found in buildup and the penumbra regions. Conclusion: The results showed that
the dose calculation using Prowess TPS based on CCCS algorithm is generally in excellent agreement with measurements.
Keywords: Symmetric and Asymmetric Fields; Dose Calculation; Treatment Planning System
Introduction
The dose calculation algorithm must accurately model for all
beam configurations normally used in the clinic. Radiation
therapy treatment planning for many clinical situations re-
quires asymmetric field size correctly modeled in the treat-
ment planning computer system. This includes verifying the
accuracy of both the isodose distributions and the monitor
units (MUs) generated by the treatment planning system.1-3
The degree of success achieved by the optimization process is
largely dependent on the cost function used by the algorithm
(which in turn depends on the structures defined by the
user) and the algorithm used for minimization.4 Several au-
thors have conducted the evaluation of dose calculation al-
gorithms for external beam radiation therapy.5-7
Commissioning of the dose calculation algorithms of a
treatment planning system is generally performed: (i) by
entering basic beam data into the system according to the
methods and requirements described in the user's manual of
the system; and (ii) by comparing the results of dose calcula-
tions with the entered data and with data that were meas-
ured specifically for this purpose. Most commonly, existing
beam data are used as input data. Differences between calcu-
lated and actual dose values may be encountered, partly due
to uncertainties in the measured data, and partly due to im-
perfect beam modeling. Criteria for acceptability have to be
applied before accepting a treatment planning system for
clinical use. Several authors have developed such criteria.8
Several treatment planning systems calculate asymmetric
fields on the assumption that these are equivalent to blocked
fields. However, the parameters required for treatment plan-
ning implementation depend on the algorithm used, and the
method of their derivation is often not explicit. Since asym-
metric fields are the simplest case of irregular fields, others
have approached this problem using appropriate algorithms
that utilize the data available for symmetric fields.9
The collapse cone convolution algorithm is a point kernel
convolution model that convolves a polyenergetic spectrum
to the point kernel energy distribution and kernels correc-
tion during the convolution process is its main advantage.10
Ahnesjö introduced CCC algorithm and for the first time,
compared their dose calculation results with the Batho
method A model may be capable to consider a given physical
effect, but the actual implementation in the software is often
simplified and can be resulted to inaccuracy or unexpected
consequences. Thus many researches have verified the accu-
racy of the CCC algorithm against other dose calculation
methods in different treatment planning systems (TPSs) and
various clinical situations.11 Prowess TPS has been available
commercially for several years. As yet, however, there have
been few reports 12, 13 studied the performance of Prowess
TPS. The aim of our work is to determine the accuracy of
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Prowess TPS in dose calculation in a homogenous phantom
for symmetric and asymmetric field size using collapse cone
convolution/superposition algorithm.
Methods and Materials
The study was performed on a Siemens Artiste Linear Accel-
erator machine (Siemens Medical Solutions UK) for the 6
and 10 MV X-ray beam available at Alexandria Ayadi
Al-Mostakbal Oncology Center. A computerized water tank
system was used for dose measurements PTW dosimetry
system (PTW, Freiburg, Germany) with two semiflex (0.125
cc) ionization chamber. The measurements were carried out
at source-to-surface distance (SSD) set to 100 cm. Data for a
full set of measurements for symmetric fields and asymmet-
ric fields, including inplane and crossplane profiles at various
depths and percentage depth doses (PDDs) were obtained
during measurements on the linear accelerator. The position
of the ionization chamber is critical in the case of asymmet-
ric beams due to the dose gradient. The chamber was
mounted in a holder, placed in a 50 cm × 50 cm × 50 cm
PTW three dimensional water phantom. The gantry of the
treatment unit was set to 0°. The linac was set to deliver 200
monitor units (MUs) per minute. To reduce the variability of
working conditions, the dosimetry measurements were per-
formed in a single session. The dose distributions were cal-
culated by Prowess Panther version 5 (Prowess inc., Con-
cord, CA) 3D planning system 3DTPS. The measured isodose
was compared with the calculated isodose obtained from the
Prowess TPSs under the same conditions as measured iso-
doses. The comparison made by using PTW VeriSoft soft-
ware, Version 4 (PTW, Freiburg, Germany), and the refer-
ence isodose was the measured isodoses.
To verify agreement over the range of symmetric and asym-
metric field sizes used clinically. Asymmetric fields obtained
by shifting one or two of the collimator jaws across the col-
limator axis for the flowing field sizes 4 cm × 4 cm and 10 cm
× 10cm. The different symmetric asymmetric field size was
used in this study, for 4 cm × 4 cm and 10 cm × 10 cm
showed in Table 1, Figure 1 showed view of the beam setup
at different depths of measurement (a) in the asymmetrical
setting (X1 = 1, X2 = 3, Y1 = 2, Y2 = 2), (b) in the symmet-
rical setting (X1 = 2, X2 = 2, Y1 = 2, Y2 = 2), and (c) in the
asymmetrical setting (X1 = 3, X2 = 1, Y1 = 2, Y2 = 2). Central
axis depth dose and beam profiles measured at different
depths (Dmax, 5, 10, and 20 cm) and normalized to the value
of dmax at the center. All data measured for inplane and
crossplane direction at fixed SSD = 100 cm and for 6 and 10
MV for ARTISTE linac. Calculation was performed in a
phantom created by the Prowess TPS used in this study with
a homogeneous density of 1 g/cm3, the dose grid used were 3
mm × 3 mm.
FIG. 1: View of the beam setup showing the depths of measurement (a) in the asymmetrical setting (X1 = 1, X2 = 3, Y1 = 2, Y2 = 2); (b) in the
symmetrical setting (X1 = 2, X2 = 2, Y1 = 2, Y2 = 2); and (c) in the asymmetrical setting (X1 = 3, X2 = 1, Y1 = 2, Y2 = 2).
TABLE 1: Symmetric and asymmetric field sizes for crossplane and inplane direction.
Field size (4 cm × 4 cm)
No of Fields
Examined
Crossplane Direction Inplane Direction
X1 X2 Y1 Y2 X1 X2 Y1 Y2
1 1 3 2 2 2 2 1 3
2 2 2 2 2 2 2 2 2
3 3 1 2 2 2 2 3 1
Field size (10 cm × 10 cm)
1 2 8 5 5 5 5 2 8
2 3 7 5 5 5 5 3 7
3 4 6 5 5 5 5 4 6
4 5 5 5 5 5 5 5 5
5 6 4 5 5 5 5 6 4
6 7 3 5 5 5 5 7 3
7 8 2 5 5 5 5 8 2
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Calculated dose validation
In order to compare calculated and measured doses, we used
PTW VeriSoft software (Version 4) to verify the treatment
plan by comparing calculated data to its corresponding
measured in phantom.
According to the tolerance values for homogeneous simple
fields, the penumbra region should be within 2 mm or
10%.14-15 By just studying the profiles by eye it is hard to say,
especially in the z-direction in the penumbra region, if the
result is within the tolerance. A gamma evaluation with 3%
and 3 mm criteria, revealing that it is only in the penumbra
region that acceptance fails. The colors of the palette range
are set to be green for 100% (γ = 1), and accepted regions are
green and most yellow. Regions that fail are shown in red.
The gamma evaluation method is not a good tool for evalua-
tion of low dose regions, where the calculation can fail
though it is within the set criteria. For example if we are
comparing two dose points of 4% and 1% dose, and the dose
criteria is set to be 2%, this will lead to a gamma value larger
than 1 ((4%-1%)/2%). The 3% dose difference can still be
within acceptable tolerances but the gamma calculation fails.
The acceptance criteria for evaluation between two plans
using gamma index, varies from user to user. For example,
some authors considered a dose difference criteria of ΔD = 5
%/5 mm and others as VanDyk et al. used 3%/3 mm. We
used the VanDyk criteria in our analysis.16 The criteria used
is 3%-3 mm with the expectation that >90% of the points
tested passing the 3%-3 mm criterion would be a minimum
acceptable threshold.
The difference matrix of two detector array matrices is de-
termined by comparison of the measured and the calculated
asymmetric field sizes are expressed as a percentage of the
locally measured dose by using the following equation:
Diffrence (%) = (Dcalculated-Dmeasured)/Dmeasured) × 100
(1)
Results
The results of isodose curves for 6 and 10 MV and two
opened field size 4 cm × 4 cm and 10 cm x 10 cm at 100 cm
SSD were obtained. The measured isodose curves (measured
by ionization chamber) compared with the calculated iso-
dose curves (obtained from TPS) using γ-index evaluation for
all asymmetric field sizes. Figure 2 to 5 showed comparison
of the dose distribution by the gamma method for both en-
ergies and different open asymmetric field size for Prowess
treatment planning system. The results of the comparison
were tabulated using the gamma method in Table 2 and 3 for
field size 4 cm × 4 cm, Table 4 and 5 contains results for field
size 10 cm × 10 cm.
Table 2 contained the percentage passing rate for the gamma
index between measured and calculated symmetric and
asymmetric field size obtained from field size 4 cm × 4 cm
for both direction at 6 MV for Prowess treatment planning
systems, it also contains the percentage failed rate between
measured and calculated obtained from Prowess TPS. In
crossplane direction the maximum difference was found at
(X1 = 1, X2 = 3 & Y1 = 2, Y2 = 2), it equals to 5.5%. In
inplane direction the maximum difference was found at (X1
= 2, X2 = 2 & Y1 = 1, Y2 = 3), it equals to 9%. The difference
for most asymmetric fields was less than 5% except three
points. Figure 6 showed the difference between measured
and calculated for crossplane and inplane at 6 MV. Table 3
contains the percentage passing rate for the gamma index
between measured and calculated symmetric and asymmet-
ric field size obtained from field size 4cm × 4cm for both
direction at 10 MV. In crossplane direction the maximum
difference was found at (X1 = 1, X2 = 3 & Y1 = 2, Y2 = 2), it
equals to 3.6%. In inplane direction the maximum difference
was found at (X1 = 2, X2 = 2 & Y1 = 1, Y2 = 3), it equals to
4.5%. The difference for all asymmetric fields was less than
5%. Figure 6 showed the difference between measured and
calculated for crossplane and inplane at 10MV.
FIG. 2: Gamma distribution for different field using the full CCCS algorithm for 6 MV for field size 4 cm × 4 cm with different offsets. The up-
per parts represents the crossplane direction comparison, while the lower part represents the inplane direction comparison, the green color
indicates regions where gamma ≤ 1; and red indicates gamma > 1 (individual criteria: Δ%D = 3%, DTA = 3 mm). For crossplane di rection (a) (X1
= 1, X2 = 3, Y = 4); (b) (X1 = 2, X2 = 2, Y = 4); and (c) (X1 = 3, X2 = 1, Y = 4). For inplane direction (X = 4, Y1 = 1, Y2 = 3); (b) (X = 4, Y1 = 2, Y2 =
2); and (c) (X = 4, Y1 = 3, Y2 = 1).
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TABLE 2: Difference between measured dose and calculated dose at different isodose lines for crossplane and inplane asymmetric fields for field
size 4 cm × 4 cm at 6 MV.
GAMMA INDEX (3 mm)
Crossplane Direction 6 MV
Point
No.
Field
Size(cm2)
Evaluated
Dose Points
Passed
Points
Failed
Points
Matching
Result
1 (1,3) 100%
100%
100%
94.50% 5.50% 94.50%
2 (2,2) 95.90% 4.10% 95.90%
3 (3,1) 94.70% 5.30% 94.70%
Inplane Direction 6 MV
1 (1,3) 100%
100%
100%
91.00% 9.00% 91.00%
2 (2,2) 96.10% 3.90% 96.10%
3 (3,1) 97.00% 3% 97.00%
FIG. 3: Gamma distribution for different field using the full CCCS algorithm for 10 MV for field size 4 cm × 4 cm with different offsets.
TABLE 3: Difference between measured dose and calculated dose at different isodose lines for crossplane and inplane asymmetric fields for field
size 4 cm × 4 cm at 10 MV.
GAMMA INDEX (3 mm)
Crossplane Direction 10 MV
Point
No.
Field
Size(cm2)
Evaluated
Dose Points
Passed
Points
Failed
Points
Matching
Result
1 (1,3) 100%
100%
100%
97.30% 2.70% 97.30%
2 (2,2) 97.70% 2.30% 97.70%
3 (3,1) 96.40% 3.60% 96.40%
Inplane Direction 10 MV
1 (1,3) 100%
100%
100%
95.50% 4.50% 95.50%
2 (2,2) 97.60% 2.40% 97.60%
3 (3,1) 97.00% 3% 97.00%
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FIG. 4: Gamma distribution for different field using the CCCS algorithm for 6 MV for field size 10 cm × 10 cm with different offsets. The upper
parts represent the crossplane direction comparison, while the lower part represents the inplane direction comparison.
TABLE 4: Difference between measured dose and calculated dose at different isodose lines for crossplane and inplane asymmetric fields for field
size 10 cm × 10 cm at 6 MV.
GAMMA INDEX (3mm)
Crossplane Direction 6 MV
Point
No.
Field
Size(cm2)
Evaluated
Dose Points
Passed
Points
Failed
Points
Matching
Result
1 (2,8) 100%
100%
100%
100%
100%
100%
100%
97.60% 2.40% 97.60%
2 (3,7) 97.90% 2.10% 97.90%
3 (4,6) 98.10% 1.90% 98.10%
4 (5,5) 98.70% 1.30% 98.70%
5 (6,4) 98.60% 1.40% 98.60%
6 (7,3) 98.50% 1.50% 98.50%
7 (8,2) 98.00% 2% 98.00%
Inplane Direction 6 MV
Point
No.
Field
Size(cm2)
Evaluated
Dose Points
Passed
Points
Failed
Points
Matching
Result
1 (2,8) 100%
100%
100%
100%
100%
100%
100%
99.00% 1.00% 99.00%
2 (3,7) 98.20% 1.80% 98.20%
3 (4,6) 98.60% 1.40% 98.60%
4 (5,5) 99.10% 0.90% 99.10%
5 (6,4) 98.70% 1.30% 98.70%
6 (7,3) 98.00% 2.00% 98.00%
7 (8,2) 96.70% 3% 96.70%
FIG. 5: Gamma distribution for different field using the CCCS algorithm for 10 MV for field size 10 cm × 10 cm with different offsets. The upper
parts represent the crossplane direction comparison, while the lower part represents the inplane direction comparison.
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TABLE 5: Difference between measured dose and calculated dose at different isodose lines for crossplane and inplane asymmetric fields for field
size 10 cm × 10 cm at 10 MV.
GAMMA INDEX (3mm)
Crossplane Direction 10MV
Point
No.
Field
Size(cm2)
Evaluated
Dose Points
Passed
Points
Failed
Points
Matching
Result
1 (2,8) 100%
100%
100%
100%
100%
100%
100%
97.30% 2.70% 97.30%
2 (3,7) 99.50% 0.50% 99.50%
3 (4,6) 99.20% 0.80% 99.20%
4 (5,5) 99.30% 0.70% 99.30%
5 (6,4) 99.00% 1.00% 99.00%
6 (7,3) 97.40% 2.60% 97.40%
7 (8,2) 98.70% 1% 98.70%
Inplane Direction 10MV
Point
No.
Field
Size(cm2)
Evaluated
Dose Points
Passed
Points
Failed
Points
Matching
Result
1 (2,8) 100%
100%
100%
100%
100%
100%
100%
96.50% 3.50% 96.50%
2 (3,7) 98.00% 2.00% 98.00%
3 (4,6) 98.20% 1.80% 98.20%
4 (5,5) 99.00% 1.00% 99.00%
5 (6,4) 98.80% 1.20% 98.80%
6 (7,3) 96.60% 3.40% 96.60%
7 (8,2) 98.40% 1.60% 98.40%
FIG. 6: Comparison between crossplane and inplane difference for 4 cm × 4 cm with different offsets for 6 MV and 10 MV.
FIG. 7: Comparison between crossplane and inplane difference for 10 cm × 10 cm with different offsets for 6 MV and 10 MV.
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Table 4 presents the percentage passing rate for the gamma
index between measured and calculated symmetric and
asymmetric field size obtained from field size 10 cm × 10 cm
for both direction at 6 MV. In crossplane direction the
maximum difference was found at (X1 = 2, X2 = 8 & Y1 = 5,
Y2 = 5), it equals to 2.4% TPS. In inplane direction the
maximum difference was found at (X1 = 5, X2 = 5 & Y1 = 8,
Y2 = 2), it equals to 3%. The difference for all asymmetric
fields was less than or equal to 3%, and the uncertainty limi-
tation of this work equals to ±3%. Figure 7 Showed the dif-
ference between crossplane and inplane for 10MV. Table 5
percentage passing rate for the gamma index between meas-
ured and calculated symmetric and asymmetric field size
obtained from field size 10 cm × 10 cm for both directions at
10MV. In crossplane direction the maximum difference was
found at (X1 = 2, X2 = 8 &Y1 = 5, Y2 = 5), it equals to 2.7%.
In inplane direction the maximum difference was found at
(X1 = 5, X2 = 5 & Y1 = 2, Y2 = 8), it equals to 3.5%. The dif-
ference for all asymmetric fields was less than 3% except two
points. Figure 7 showed the difference between measured
and calculated for crossplane and inplane at 10 MV.
Discussion
Quality assurance of treatment planning systems has been
the subject of study of several groups of physicists, formulat-
ing recommendations for the commissioning and routine
quality control of these systems.8Different types of studies
can be distinguished. Sauer et al.17 presented studies, in
which the performance of one specific treatment planning
system was discussed, using machine data obtained in the
same clinic and comparing these data with results of calcula-
tions. The asymmetric fields is smaller than the symmetric
field in one dimension, this reduction leads to decrease in
the absorbed dose in this direction which made significant
alteration in the depth dose and beam profile.The beam pro-
file and isodose lines for the asymmetric field differ than the
symmetric field with the same field size; this difference is
due to that the asymmetric field intercepts different posi-
tions in the flatting filter which leads to decrease in scattered
radiation in one side than the other side. This effect leads to
tilt in one side (wedge effect) of the beam profile and isodose
lines.
In this study, dose calculation accuracy of CCCS has been
evaluated by comparing the measured and calculated isodose
lines in homogeneous water phantom. The data showed that
the difference in the small asymmetric fields higher than the
larger asymmetric fields. The average difference between
measured and calculated field size 4 cm × 4 cm with different
offsets is 4.11 ± 0.02, while for field size 10 cm × 10 cm with
different offsets is 1.73 ± 0.008 for Prowess TPS. The com-
parison between measured and calculated dose made by
gamma index method showed that the average difference for
asymmetric fields is less than 3%. Except for field size 4 cm ×
4 cm, our data compared with previous data from Birgani et
al.18, El-Attar et al.9, Chegeni and Birgani19, 20, and Murugan
et al.21 Asymmetric collimation dose lead to significant errors
(up to approximately 7%) in dose calculations if changes in
primary beam intensity and beam quality.22 It is obvious that
the most difference in the isodose curves was found in
buildup region and the penumbra region. Constrictions of
isodose curves at the edge nearer to central axis for asym-
metrically placed fields are obvious. This is attributed to the
decrease of primary and side scattered radiation caused by
geometrical non-divergence of the beam at that edge which
leads to wedge shape, this agreed with C. Varatharaj et al.23
The agreement between measured and calculated isodoses is
better for 10 MV than for 6 MV, where the highest differ-
ence equal to 2% was observed when both the crossplane
and inplane directions are moved to their mechanical limit
for over travel. The results showed that most data gave a
high passing rate (>97%) for the gamma index for Prowess
TPS approved the suitability of CCCS algorithm for incorpo-
ration into a treatment planning system for asymmetric
opened fields. The methodology applied in this study can
also be implemented to validate other advanced dose calcu-
lation algorithms such as Acuros XB algorithm and aniso-
tropic analytical algorithm.25-27
Conclusion
Dose calculation using Prowess TPS based on CCCS algo-
rithm is generally in excellent agreement with measure-
ments. There are some points with deviation which was not
within the limits that have been set up for dose planning
systems; the largest deviation was found at the small field
size 4 cm × 4 cm. The reason of that deviation is the uncer-
tainty in dose measurement in addition to the tilt effect.
Based on our results, the Prowess Panther v5.01 Planning
System and CCCS algorithm, were within the acceptable
accuracy limits in dosimetry. The additional dosimetry
should be done in the region above the depth of maximum
dose using a proper dosimeter.
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